BartschP, SwensonER, PaulA, JulgB, HohenhausE. (2002). Hypoxic ventilatory response, ventilation, gas exchange, and fluid balance in acute mountain sickness. High Alt Med Biol, 3:361–376.
5.
BurtscherM, FlatzM, FaulhaberM. (2004). Prediction of susceptibility to acute mountain sickness by SaO2 values during short-term exposure to hypoxia. High Alt Med Biol, 5:335–340.
6.
ChenHC, LinWL, WuJY, WangSH, ChiuTF, WengYM, HsuTY, WuMH. (2012). Change in oxygen saturation does not predict acute mountain sickness on Jade Mountain. Wilderness Environ Med, 23:122–127.
7.
DehnertC, GrünigE, MerelesD, von LennepN, BärtschP. (2005). Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude. Eur Respir J, 25:545–551.
8.
DehnertC, ScheurlenF, MerelesD, GrünigE, BärtschP. (2009). Incidence of high altitude pulmonary edema in subjects with increased hypoxic pulmonary vascular response (abstract). Hypoxia Symposium, Lake Louise, Canada.
9.
GrunigE, MerelesD, HildebrandtW, SwensonER, KublerW, KuechererH, BartschP. (2000). Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema. J Am Coll Cardiol, 35:980–987.
10.
HohenhausE, PaulA, McCulloughRE, KüchererH, BärtschP. (1995). Ventilatory and pulmonary vascular response to hypoxia and susceptibility to high altitude pulmonary oedema. Eur Respir J, 8:1825–1833.
11.
HultgrenHN, GroverRF, HartleyLH. (1971). Abnormal circulatory responses to high altitude in subjects with a previous history of high-altitude pulmonary edema. Circulation, 44:759–770.
12.
LuksAM, McIntoshSE, GrissomCK, AuerbachPS, RodwayGW, SchoeneRB, ZafrenK, HackettPH. (2010). Wilderness Medical Society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ Med, 21:146–155.
13.
MaggioriniM, Brunner-La RoccaHP, PethS, FischlerM, BohmT, BernheimA, KienckeS, BlochKE, DehnertC, NaeijeR and others. (2006). Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med, 145:497–506.
14.
MaggioriniM, BühlerB, WalterM, OelzO. (1990). Prevalence of acute mountain sickness in the Swiss Alps. Br Med J, 301:853–855.
RichaletJP, KeromesA, CarillionA, MehdiouiH, LarmignatP, RathatC. (1989). Réponse cardiaque à l'hypoxie et susceptibilité au mal des montagnes. Arch Mal Coeur Vaiss, 82:49–54.
18.
RichaletJP, LarmignatP, PoitrineE, LetournelM, Canoui-PoitrineF. (2012). Physiological risk factors of severe high altitude illness: A prospective cohort study. Am J Respir Crit Care Med, 185:1092–1098.
19.
RoachRC, GreeneER, SchoeneRB, HackettPH. (1998). Arterial oxygen saturation for prediction of acute mountain sickness. Aviat Space Environ Med, 69:1182–1185.
20.
SartoriC, LippE, DuplainH, EgliM, HutterD, AllemannY, NicodP, ScherrerU. (2000). Prevention of high-altitude pulmonary edema by beta-adrenergic stimulation of the alveolar transepithelial sodium transport (Abstract). Schweiz Med Wochenschr, 130:295
21.
SchneiderM, BernaschD, WeymannJ, HolleR, BärtschP. (2002). Acute mountain sickness: Influence of susceptibility, pre-exposure and ascent rate. Med Sci Sports Exerc, 34:1886–1891.
22.
SwensonER, MaggioriniM, MongovinS, GibbsJS, GreveI, MairbaurlH, BartschP. (2002). Pathogenesis of high-altitude pulmonary edema: Inflammation is not an etiologic factor. JAMA, 287:2228–2235.
23.
WagnerDR, D'ZatkoK, TatsugawaK, MurrayK, ParkerD, StreeperT, WillardK. (2008). Mt. Whitney: Determinants of summit success and acute mountain sickness. Med Sci Sports Exerc, 40:1820–1827.
24.
WangSH, ChenYC, KaoWF, LinYJ, ChenJC, ChiuTF, HsuTY, ChenHC, LiuSW. (2010). Epidemiology of acute mountain sickness on Jade Mountain, Taiwan: An annual prospective observational study. High Alt Med Biol, 11:43–49.
